Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 2
Submit an article Journal homepage
1,339
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Lectin galactoside-binding soluble 3 binding protein mediates methotrexate resistance in choriocarcinoma cell lines

XiaoJing Chena Key Laboratory of Women’s Reproductive Health of Zhejiang Province, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaORCID Iconhttps://orcid.org/0000-0001-8107-9037View further author information
ORCID Icon,
Yite Xuea Key Laboratory of Women’s Reproductive Health of Zhejiang Province, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaORCID Iconhttps://orcid.org/0000-0001-6180-4326View further author information
ORCID Icon,
Lingfang Wanga Key Laboratory of Women’s Reproductive Health of Zhejiang Province, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaORCID Iconhttps://orcid.org/0000-0002-2879-6739View further author information
ORCID Icon,
Yang Wengb Department of Gynecologic Oncology, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaORCID Iconhttps://orcid.org/0000-0002-8048-5858View further author information
ORCID Icon,
Sen Lia Key Laboratory of Women’s Reproductive Health of Zhejiang Province, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaView further author information
,
Weiguo Lüa Key Laboratory of Women’s Reproductive Health of Zhejiang Province, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China;b Department of Gynecologic Oncology, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaORCID Iconhttps://orcid.org/0000-0002-8570-7317View further author information
ORCID Icon,
Xing Xiea Key Laboratory of Women’s Reproductive Health of Zhejiang Province, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China;b Department of Gynecologic Oncology, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaView further author information
&
Xiaodong Chenga Key Laboratory of Women’s Reproductive Health of Zhejiang Province, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China;b Department of Gynecologic Oncology, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6073-7261View further author information
ORCID Icon show all
Pages 2076-2086 | Received 19 Oct 2021, Accepted 16 Dec 2021, Published online: 17 Jan 2022

References

  • Maestá I, Nitecki R, Horowitz NS, et al. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia the New England trophoblastic disease center experience. Gynecol Oncol. 2018;148:161–167.
  • Soper JT. Gestational trophoblastic disease: current evaluation and management. Obstet Gynecol. 2021;137:355–370.
  • Elias KM, Braga A, Horowitz NS, et al. A novel alternative to cytotoxic chemotherapy for gestational trophoblastic disease. Lancet Oncol. 2021;22:1490–1491.
  • Savage P, Kelpanides I, Tuthill M, et al. Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome. Gynecol Oncol. 2015;137:73–76.
  • Wei L, Wang C, Chen X, et al. Dual-responsive, methotrexate-loaded, ascorbic acid-derived micelles exert anti-tumor and anti-metastatic effects by inhibiting NF-κB signaling in an orthotopic mouse model of human choriocarcinoma. Theranostics. 2019;9:4354–4374.
  • Berkowitz RS, Goldstein DP. Current advances in the management of gestational trophoblastic disease. Gynecol Oncol. 2013;128:3–5.
  • Jun F, Peng Z, Zhang Y, et al. Quantitative proteomic profiling identifies SOX8 as novel regulator of drug resistance in Gestational Trophoblastic Neoplasia. Front Oncol. 2020;10:557.
  • Alazzam M, Tidy J, Osborne R, et al. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2012;12:CD008891.
  • Shan Y, Li Y, Han H, et al. Insulin reverses choriocarcinoma 5- fluorouracil resistance. Bioengineered. 2021;12:2087–2094.
  • Rushworth D, Mathews A, Alpert A, et al. Dihydrofolate reductase and thymidylate synthase transgenes resistant to methotrexate interact to permit novel transgene regulation. J Biol Chem. 2015;290:22970–22976.
  • Stampolidis P, Ullrich A, Iacobelli S. LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes oncogenic cellular events impeded by antibody intervention. Oncogene. 2015;34:39–52.
  • Woo JK, Jang J-E, Kang J-H, et al. Galactoside-binding soluble 3 binding protein promotes 17-N-Allylamino-17-demethoxygeldanamycin resistance through PI3K/Akt pathway in lung cancer cell line. Mol Cancer Ther. 2017;16:1355–1365.
  • Wu X, Qin J, Shen T, et al. The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy. J Gynecol Oncol. 2020;31:e36.
  • Läubli H, Alisson-Silva F, Stanczak MA, et al. Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs. J Biol Chem. 2014;289:33481–33491.
  • Wang Y, Cheng Z, Xu J, et al. Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-derived resistance of breast cancer to doxorubicin. Bioengineered. 2021;12:1874–1889.
  • Sun M, Chen Y, Liu X, et al. LncRNACASC9 promotes proliferation, metastasis, and cell cycle in ovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling. Bioengineered. 2021;12:8006–8019.
  • Dai W, Zhang Y, Zhang J, et al. Analysis of antibiotic-induced drug resistance of Salmonella enteritidis and its biofilm formation mechanism. Bioengineered. 2021;12:10254–10263.
  • Si L, Wang Y, Liu M, et al. Expression and role of microRNA-212/nuclear factor I-A in depressive mice. Bioengineered. 2021;12:11520–11532.
  • Wang Y, Zhou P, Li P, et al. Long non-coding RNA H19 regulates proliferation and doxorubicin resistance in MCF-7 cells by targeting PARP1. Bioengineered. 2020;11:536–546.
  • Yu S, Wu C, Tan Q, et al. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells. J Cell Biochem. 2019;120:15131–15144.
  • Wu J, Wang D. CLIC1 induces drug resistance in human choriocarcinoma through positive regulation of MRP1. Oncol Res. 2017;25:863–871.
  • Wang X, Zong L, Wang W, et al. CD105 overexpression mediates drug-resistance in choriocarcinoma cells through BMP9/Smad pathway. J Cancer. 2020;11:272–283.
  • Elias KM, Harvey RA, Hasselblatt KT, et al. Type I interferons modulate methotrexate resistance in gestational trophoblastic neoplasia. Am J Reprod Immunol (New York, N.Y.: 1989). 2017;77. DOI:10.1111/aji.12666.
  • Yu Y, Liu L, Hu -L-L, et al. Potential therapeutic target genes for systemic lupus erythematosus: a bioinformatics analysis. Bioengineered. 2021;12:2810–2819.
  • Piccolo E, Tinari N, D’Addario D, et al. Prognostic relevance of LGALS3BP in human colorectal carcinoma. J Transl Med. 2015;13:248.
  • Linsley PS, Horn D, Marquardt H, et al. Identification of a novel serum protein secreted by lung carcinoma cells. Biochemistry. 1986;25:2978–2986.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.